Tech Company Financing Transactions
Tevosol Funding Round
Tevosol, based in Edmonton AB, secured $2 million in investment from private investors.
Transaction Overview
Company Name
Announced On
8/16/2019
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to complete a proof-of-concept human trial at the University of Alberta, expand its product engineering and industrial design team, and accelerate commercial development of its portable perfusion machine for lungs.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
10230 Jasper Ave. 4261 TEC Centre
Edmonton AB, T5J 4P6
Canada
Edmonton AB, T5J 4P6
Canada
Phone
Website
Email Address
Overview
Tevosol, Inc. is a medical device company developing the Ex-Vivo Organ Support System (EVOSS) with the goal of increasing the number of organs available for transplantation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ron Mills
Chief Financial Officer
Walter Maciurzynski
Chief Scientific Officer
Darren Freed
Vice President
Jayan Nagendran
VP - Bus. Development
David Moon
VP - Operations
Shahroze Khan
Browse more venture capital transactions:
Prev: 8/16/2019: Buoy Health venture capital transaction
Next: 8/16/2019: Scoop Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs